{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T21:25:07Z","timestamp":1774560307996,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T00:00:00Z","timestamp":1593820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T00:00:00Z","timestamp":1593820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00520-020-05611-w","type":"journal-article","created":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T08:03:39Z","timestamp":1593849819000},"page":"5611-5619","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Transdermal versus oral granisetron in controlling chemotherapy-induced nausea and vomiting: a meta-analysis"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0895-8139","authenticated-orcid":false,"suffix":"Jr.","given":"Alfredo V.","family":"Chua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aylmer Rex B.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irisyl O.","family":"Real","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,4]]},"reference":[{"key":"5611_CR1","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s00520-010-0990-y","volume":"19","author":"RV Boccia","year":"2011","unstructured":"Boccia RV, Gordan LN, Clark G, Howell JD, Grunberg SM, Sancuso Study Group (2011) Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study. Support Care Cancer 19:1609\u20131617","journal-title":"Support Care Cancer"},{"key":"5611_CR2","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s00520-014-2507-6","volume":"23","author":"JE Kim","year":"2015","unstructured":"Kim JE, Hong YS, Lee JL, Kim KP, Park SJ, Sym SJ, Shin DB, Lee J, Park YS, Ahn JS, Kim TW (2015) A randomized study of the efficacy and safety of transdermal granisetron in the control of nausea and vomiting induced by moderately emetogenic chemotherapy in Korean patients. Support Care Cancer 23:1769\u20131777","journal-title":"Support Care Cancer"},{"issue":"18","key":"5611_CR3","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.2165\/11202780-000000000-00000","volume":"69","author":"ST Duggan","year":"2009","unstructured":"Duggan ST, Curran MP (2009) Transdermal granisetron. Drugs. 69(18):2597\u20132605","journal-title":"Drugs."},{"key":"5611_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1634\/theoncologist.8-2-187","volume":"8","author":"FM Schell","year":"2003","unstructured":"Schell FM (2003) Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control. Oncologist. 8:187\u2013198","journal-title":"Oncologist."},{"issue":"suppl 1","key":"5611_CR5","first-page":"5","volume":"8","author":"DG Frame","year":"2010","unstructured":"Frame DG (2010) Best practice management of CINV in oncology patients: I. physiology and treatment of CINV-multiple neurotransmitters and receptors and the need for combination therapeutic approaches. J Support Oncol 8(suppl 1):5\u20139","journal-title":"J Support Oncol"},{"issue":"16","key":"5611_CR6","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.2217\/fon-2016-0097","volume":"12","author":"F Coluzzi","year":"2016","unstructured":"Coluzzi F, Mattia C (2016) Management of chemotherapy-induced nausea and vomiting in patients receiving multi-day highly or moderately emetogenic chemotherapy: role of transdermal granisetron. Future Oncol 12(16):1856\u20131876","journal-title":"Future Oncol"},{"issue":"6","key":"5611_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.21037\/cco.2016.12.04","volume":"5","author":"LQ Yang","year":"2016","unstructured":"Yang LQ, Sun XC, Qin SK, Chen YX, Zhang HL, Cheng Y, Chen ZD, Shi JH, Wu Q, Bai YX, Han BH, Liu W, Ouyang XN, Liu JW, Zhang ZH, Li YQ, Xu JM, Yu SY (2016) Transdermal granisetron for the prevention of nausea and vomiting following moderately or highly emetogenic chemotherapy in Chinese patients: a randomized, double-blind, phase III study. Chin Clin Oncol 5(6):79","journal-title":"Chin Clin Oncol"},{"issue":"1","key":"5611_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/annonc\/mdj078","volume":"17","author":"F Roila","year":"2006","unstructured":"Roila F, Hesketh PJ, Herrstedt J, Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (2006) Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference. Ann Oncol 17(1):20","journal-title":"Ann Oncol"},{"issue":"10","key":"5611_CR9","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/1078-0432.CCR-11-2785","volume":"18","author":"JW Mason","year":"2012","unstructured":"Mason JW, Selmess DS, Moon TE, O\u2019Mahony B, Donachie P, Howell J (2012) Pharmacokinetics and repolarization effects of intravenous and transdermal granisetron. Clin Cancer Res 18(10):2913\u20132921","journal-title":"Clin Cancer Res"},{"issue":"4","key":"5611_CR10","first-page":"475","volume":"23","author":"M Al Harbi","year":"2016","unstructured":"Al Harbi M, Al Rifai D, Al Habeeb H, Wambi F, Geldhof G, Dimitiou V (2016) A case of granisetron associated intraoperative cardiac arrest. Middle East J Anesthesiol 23(4):475\u2013478","journal-title":"Middle East J Anesthesiol"},{"key":"5611_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2147\/CMAR.S58071","volume":"6","author":"JW Mason","year":"2014","unstructured":"Mason JW, Moon TE, O\u2019Boyle EO, Dietz A (2014) A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongation. Cancer Manag Res 6:181\u2013190","journal-title":"Cancer Manag Res"},{"key":"5611_CR12","unstructured":"Higgins JPT, Green S (editors) (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration http:\/\/handbook.cochrane.org. Accessed 23 Jan 2018"},{"key":"5611_CR13","first-page":"1","volume":"2","author":"A Tuca","year":"2010","unstructured":"Tuca A (2010) Use of granisetron transdermal system in the prevention of chemotherapy-induced nausea and vomiting: a review. Cancer Manag Res 2:1\u201312","journal-title":"Cancer Manag Res"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05611-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-020-05611-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05611-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T23:27:06Z","timestamp":1625354826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-020-05611-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,4]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5611"],"URL":"https:\/\/doi.org\/10.1007\/s00520-020-05611-w","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,4]]},"assertion":[{"value":"3 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}